renumeration waiver22 Dec 2022 07:17
Saving of £300,000 plus on salaries. Only correct with a market value of the company being £5,000,000. They cannot have the bigger wages that a big pharma could pay. Only correct. Have enough cash to see them through until the 1st half of 2024 so no dilution any time soon. BIG PLUS.
Strong rise to 2.0 pence, should be expected.